Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2022 | Health inequalities in red cell disorders

In this video, Subarna Chakravorty, MBBS, MRCPCH, FRCPath, PhD, King’s College Hospital NHS Foundation Trust, London, UK, discusses health inequalities in red cell disorders, drawing focus on sickle cell disease (SCD). Dr Chakravorty highlights the lack of access to quality care in SCD, the goal of the recent APPG report to improve this, and the need for practitioners to continue to improve the overall quality of care provided to patients. This interview took place at the 62nd Annual Scientific Meeting of the British Society for Haematology (BSH) 2022, in Manchester, UK.

Transcript (edited for clarity)

So, health inequalities is very, very prevalent in this world where more so now that we’ve had COVID and we’ve understood how the outcomes of COVID has been different. Even within the UK, we’ve had different health outcomes, depending on socioeconomic status on your ethnic background, and particularly ethnic minority people doing much worse compared to white ethnicity people. So that has been an interesting thing...

So, health inequalities is very, very prevalent in this world where more so now that we’ve had COVID and we’ve understood how the outcomes of COVID has been different. Even within the UK, we’ve had different health outcomes, depending on socioeconomic status on your ethnic background, and particularly ethnic minority people doing much worse compared to white ethnicity people. So that has been an interesting thing. Having worked in the sickle cell field for many, many years, I’m acutely aware of an overall lack of access to good quality care that sickle cell patients are being subject to.

Everyone now is aware that in England, there has been a recent report which was published by the parliament, the All Party Parliamentary Group in conjunction with the Sickle Cell Society, which really brought home something that sickle cell practitioners knew for a very long time, which is that there is great disparity in the kind of care, the quality of care, the timeliness of care, the associated stigma, and so on that’s associated with sickle cell care. So yes, health inequalities is important, and we are here to try and bridge those inequalities, think about how best we can help level the field, if you like.

Read more...

Disclosures

Advisory board – GBT, Forma, Novartis